103
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Studies on the phenylethanoid glycosides with anti-complement activity from Paulownia tomentosa var. tomentosa wood

, , , , &
Pages 1003-1008 | Received 08 Oct 2007, Accepted 05 May 2008, Published online: 22 Nov 2008
 

Abstract

Four epimeric phenylethanoid glycosides, including a new one, R,S-β-ethoxy-β-(3,4-dihydroxyphenyl)-ethyl-O-α-l-rhamnopyranosyl(1 → 3)-β-d-(6-O-E-caffeoyl)-glucopyranoside named isoilicifolioside A (1), and three known compounds, ilicifolioside A (2), campneoside II (3), and isocampneoside II (4), were isolated from Paulownia tomentosa var. tomentosa wood. The structures of the four compounds were elucidated by the interpretation of 1D and 2D NMR and MS spectra. This is the first report of the chemical profile of this tree. Compounds 14 exhibited excellent anti-complement activity with IC50 values less than 74 μM, compared with tiliroside (IC50 = 104 μM) and rosmarinic acid (IC50 = 182 μM) that were used as positive controls.

Acknowledgements

This project was financially supported by China Postdoctoral Science Foundation (20070410198), the Natural Science Foundation of Tianjin City and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China (no. 2008-101). We are also thankful to Dr Ji-Sook Ryu, Central Laboratory of Kangwon National University, for measuring the NMR spectra.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.